EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
lymph node |
peripheral lymph nodes and mesenteric lymph nodes |
700178 |
1.1.1.205 | IMP dehydrogenase |
lymph node |
high expression |
761406 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
lymph node |
21% mRNA expression of Rdh5 compared to liver |
690797 |
1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (NAD+) |
lymph node |
peripheral lymph nodes and mesenteric lymph nodes |
700178 |
1.13.11.31 | arachidonate 12-lipoxygenase |
lymph node |
- |
395410 |
1.13.11.33 | arachidonate 15-lipoxygenase |
lymph node |
- |
639264 |
1.13.11.52 | indoleamine 2,3-dioxygenase |
lymph node |
- |
713448 |
1.14.11.4 | procollagen-lysine 5-dioxygenase |
lymph node |
- |
725955 |
1.14.18.2 | CMP-N-acetylneuraminate monooxygenase |
lymph node |
- |
639329, 639330 |
1.2.3.8 | pyridoxal oxidase |
lymph node |
larva |
390446 |
1.3.1.70 | DELTA14-sterol reductase |
lymph node |
LBR |
672378 |
1.3.1.70 | DELTA14-sterol reductase |
lymph node |
TM7SF2 |
672378 |
1.4.3.5 | pyridoxal 5'-phosphate synthase |
lymph node |
4.6% of the activity in liver |
655483 |
1.5.1.20 | methylenetetrahydrofolate reductase [NAD(P)H] |
lymph node |
- |
684441 |
1.8.4.2 | protein-disulfide reductase (glutathione) |
lymph node |
- |
394828 |
2.1.1.1 | nicotinamide N-methyltransferase |
lymph node |
- |
703943 |
2.1.1.72 | site-specific DNA-methyltransferase (adenine-specific) |
lymph node |
- |
719373 |
2.3.1.299 | sphingoid base N-stearoyltransferase |
lymph node |
- |
755995 |
2.3.1.67 | 1-alkylglycerophosphocholine O-acetyltransferase |
lymph node |
- |
487379 |
2.3.1.B43 | protein-lysine desuccinylase (NAD+) |
lymph node |
- |
755970 |
2.4.1.122 | N-acetylgalactosaminide beta-1,3-galactosyltransferase |
lymph node |
- |
759109 |
2.4.1.145 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
lymph node |
- |
703913 |
2.4.1.152 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase |
lymph node |
rFuc-TVII mRNA expression strongly detected in rat lymph node |
660733 |
2.4.1.206 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase |
lymph node |
low content |
638235 |
2.4.1.274 | glucosylceramide beta-1,4-galactosyltransferase |
lymph node |
- |
714294 |
2.4.1.38 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase |
lymph node |
- |
687078 |
2.4.1.40 | glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase |
lymph node |
A-type enzyme expression |
658843 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
lymph node |
mostly inguinal lymph nodes, not Peyerยs patch tissue, ppGalNAcT-1 activity regulates L-selectin ligand level in high endothelial venules that is responsible for lymph node cellularity and B- and T-cell homing |
688968 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
lymph node |
Northern blot analysis of human tissues |
659136 |
2.4.1.69 | type 1 galactoside alpha-(1,2)-fucosyltransferase |
lymph node |
mRNA of FTA and FTC |
489369 |
2.4.2.1 | purine-nucleoside phosphorylase |
lymph node |
- |
489654 |
2.4.2.28 | S-methyl-5'-thioadenosine phosphorylase |
lymph node |
- |
671628 |
2.4.3.2 | beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3-sialyltransferase |
lymph node |
- |
744836 |
2.7.1.138 | ceramide kinase |
lymph node |
- |
661653, 691965 |
2.7.1.154 | phosphatidylinositol-4-phosphate 3-kinase |
lymph node |
isozyme p85 in medulla, germinal centre mononuclear cells, low amount in polymorphnuclear leucocytes, and high amount in tissue macrophages, isozyme PI3K-C2alpha and isozyme PI3K-C2beta in medulla, tissue macrophages, and germinal centre mononuclear cells, high amount of isozyme PI3K-C2alpha in polymorphnuclear leucocytes |
645046 |
2.7.1.154 | phosphatidylinositol-4-phosphate 3-kinase |
lymph node |
PI3K-C2beta is highly expressed in lymph-nodes metastases compared to matching primary tumors |
739216 |
2.7.1.154 | phosphatidylinositol-4-phosphate 3-kinase |
lymph node |
weak expression of PI3K-C2alpha and PI3K-C2beta in germinal centre mononuclear cells, moderate expression of PI3K-C2alpha and PI3K-C2beta in tissue macrophages, strong expression of PI3K-C2alpha in polymorphonuclear leucocytes, weak expression of PI3K-C2alpha and moderate expression of PI3K-C2beta in medulla mononuclear cells, no expression in lymphoid follicles |
645046 |
2.7.1.48 | uridine/cytidine kinase |
lymph node |
uridine kinases mRNA expression |
641654 |
2.7.1.74 | deoxycytidine kinase |
lymph node |
normal and leukemic |
641945 |
2.7.1.91 | sphingosine kinase |
lymph node |
isozymes SPHK1 and SPHK2 |
661860 |
2.7.1.91 | sphingosine kinase |
lymph node |
low activity of isozyme SPHK1 and isozyme SPHK2 |
662167 |
2.7.1.94 | acylglycerol kinase |
lymph node |
- |
739741 |
2.7.11.19 | phosphorylase kinase |
lymph node |
- |
676038 |
2.7.12.2 | mitogen-activated protein kinase kinase |
lymph node |
strongest expression in human immune panel |
677913 |
2.7.4.14 | UMP/CMP kinase |
lymph node |
- |
645160 |
2.7.4.3 | adenylate kinase |
lymph node |
- |
705850 |
2.7.4.3 | adenylate kinase |
lymph node |
moderate expression |
722394 |
2.8.1.1 | thiosulfate sulfurtransferase |
lymph node |
- |
645530 |
2.8.2.17 | chondroitin 6-sulfotransferase |
lymph node |
- |
645765 |
2.8.2.21 | keratan sulfotransferase |
lymph node |
expressed in high endothelial venules of lymph nodes |
725108 |
2.8.2.21 | keratan sulfotransferase |
lymph node |
peripheral |
673887 |
2.8.2.5 | chondroitin 4-sulfotransferase |
lymph node |
- |
645919, 760408 |
2.8.2.5 | chondroitin 4-sulfotransferase |
lymph node |
isozyme C4ST, low content |
645919 |
2.8.2.5 | chondroitin 4-sulfotransferase |
lymph node |
isozyme C4ST1 expression |
645917 |
3.1.21.1 | deoxyribonuclease I |
lymph node |
- |
134204 |
3.1.22.1 | deoxyribonuclease II |
lymph node |
low levels |
651407 |
3.1.3.2 | acid phosphatase |
lymph node |
- |
666100 |
3.1.3.48 | protein-tyrosine-phosphatase |
lymph node |
- |
694827 |
3.1.4.11 | phosphoinositide phospholipase C |
lymph node |
metastases |
691606 |
3.1.4.11 | phosphoinositide phospholipase C |
lymph node |
PLC-gamma2 |
691473 |
3.1.4.12 | sphingomyelin phosphodiesterase |
lymph node |
- |
750622 |
3.1.4.39 | alkylglycerophosphoethanolamine phosphodiesterase |
lymph node |
- |
700364 |
3.1.6.2 | steryl-sulfatase |
lymph node |
strong positive immunostaining for enzyme |
681644 |
3.2.1.166 | heparanase |
lymph node |
- |
731867 |
3.2.1.18 | exo-alpha-sialidase |
lymph node |
- |
654541 |
3.2.1.18 | exo-alpha-sialidase |
lymph node |
low expression of Neu-2 |
654541 |
3.2.1.76 | L-iduronidase |
lymph node |
moderate activity |
171573 |
3.3.2.10 | soluble epoxide hydrolase |
lymph node |
- |
663275 |
3.4.13.9 | Xaa-Pro dipeptidase |
lymph node |
- |
683363 |
3.4.14.5 | dipeptidyl-peptidase IV |
lymph node |
- |
679710, 703678 |
3.4.14.5 | dipeptidyl-peptidase IV |
lymph node |
in lymph nodes DPIV represents 62% of the total Gly-L-Pro-4-nitroanilide-hydrolyzing activity |
697386 |
3.4.14.9 | tripeptidyl-peptidase I |
lymph node |
- |
664560 |
3.4.16.5 | carboxypeptidase C |
lymph node |
macrophage-like cells |
665905 |
3.4.17.23 | angiotensin-converting enzyme 2 |
lymph node |
- |
762703 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
lymph node |
- |
698156 |
3.4.21.26 | prolyl oligopeptidase |
lymph node |
- |
732260 |
3.4.22.15 | cathepsin L |
lymph node |
metastatic cervical lymph node |
711945 |
3.4.22.27 | cathepsin S |
lymph node |
- |
647978, 668394, 680995, 692671 |
3.4.22.43 | cathepsin V |
lymph node |
- |
707906 |
3.4.22.56 | caspase-3 |
lymph node |
- |
670069 |
3.4.22.56 | caspase-3 |
lymph node |
inguinal lymph node, ILN cell |
699714 |
3.4.23.5 | cathepsin D |
lymph node |
- |
712050 |
3.4.24.11 | neprilysin |
lymph node |
- |
81623, 81625, 81631 |
3.4.24.63 | meprin B |
lymph node |
meprin beta is expressed in leukocytes of the draining lymph node of the intestine, regardless of the inflammatory status of the animal |
669708 |
3.4.24.81 | ADAM10 endopeptidase |
lymph node |
there is expression of the enzyme |
644075 |
3.4.24.82 | ADAMTS-4 endopeptidase |
lymph node |
metastatic lymph node |
698148 |
3.4.24.B11 | ADAMTS1 endopeptidase |
lymph node |
metastatic lymph node |
698148 |
3.4.24.B12 | ADAMTS5 endopeptidase |
lymph node |
metastatic lymph node |
698148 |
3.5.1.28 | N-acetylmuramoyl-L-alanine amidase |
lymph node |
- |
172016 |
3.5.1.92 | pantetheine hydrolase |
lymph node |
- |
718754 |
3.5.4.4 | adenosine deaminase |
lymph node |
- |
209610 |
3.6.1.13 | ADP-ribose diphosphatase |
lymph node |
- |
655991 |
3.6.1.13 | ADP-ribose diphosphatase |
lymph node |
low activity |
209946 |
3.6.1.28 | thiamine-triphosphatase |
lymph node |
- |
668963 |
3.6.1.28 | thiamine-triphosphatase |
lymph node |
220 nmol per min per mg of wet weight |
655198 |
3.6.1.5 | apyrase |
lymph node |
- |
210150 |
4.1.1.22 | histidine decarboxylase |
lymph node |
in the acute phase of infection of mice infected with Leishmania major, detected in both strains the resistant C57BL/6 and the susceptible BALB/c. Only susceptible mice known to be unable to control parasite dissemination show induction of histidine decarboxylase in their distant periaortic lymph nodes as well. During the chronic phase of infection only the heavily parasitized organs of BALB/c mice show high expression of histidine decarboxylase gene |
665183 |
4.1.2.27 | sphinganine-1-phosphate aldolase |
lymph node |
sphingosine-1-phosphate lyase expression is almost exclusively restricted to cells on the parenchymal side of marginal reticular cells, consistent with a role in maintaining the S1P gradient between the sinuses and the parenchyma |
727416 |
5.1.3.17 | heparosan-N-sulfate-glucuronate 5-epimerase |
lymph node |
- |
-, 704951 |
5.3.99.5 | thromboxane-A synthase |
lymph node |
- |
3183 |